Clinical Trial

Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter, observational, descriptive study of the diagnosis, course and treatment of patients with SLE in routine practice in Kazakhstan: a registry study with retrospective and prospective components.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2025-03-26; most recent amendment 2026-06-12.
Status change: Recruiting → Active, Not Recruiting 2026-03-16
Status change: Not Yet Recruiting → Recruiting 2025-05-29
Trial Details
NCT Number NCT06899633
Lead Sponsor AstraZeneca
Conditions Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan, Description of the Course of SLE in Patients in the Republic of Kazakhstan, Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of Kazakhstan
Enrollment 509 participants
Start Date 2025-05-15
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-15